Obese polycystic ovary syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Meet the diagnostic criteria of Western medicine. 2) Female individuals aged between 18 and 40 years old. 3) Have not taken any hormonal drugs or other medications that may affect the levels of reproductive endocrine hormones within the past three months. 4) The subjects give their informed consent and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients with uterine fibroids, adenomyosis, or ovarian tumors. 2) Patients with impaired liver and kidney function, cardiovascular and cerebrovascular diseases, abnormal adrenal function, diabetes, or thyroid diseases. 3) Patients who have taken oral hormones or used contraceptives within the past three months. 4) Patients with comorbid mental diseases or cancer. 5) Patients with allergic constitution. 6) Subjects with poor compliance or those who cannot attend regular follow-up appointments. 7) Patients who are prone to fainting at the sight of needles or are afraid of needles.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Female reproductive hormones; | — |
Secondary
| Measure | Time frame |
|---|---|
| MPCOSQ(Modified PolycysticOvary Syndrome Health Related Quality of Life Questionnaire);SAS (Self-Rating Anxiety Scale);Menstrual cycle score;Body Mass Index (BMI);SF-36 (The 36-Item Short Form Health Survey questionnaire);Menstrual cycle frequency;Blood-fat;GAGS (Global Acne Grading System);SDS(Self-Rating Depression Scale);Number of antral follicles under ultrasound (during the follicular phase of the menstrual cycle);waistline;hipline;mF-G score (modified Ferri-Man-Gallway score);Waist-hip Ratio(WHR); | — |
Countries
China
Contacts
Dongzhimen Hospital, Beijing University of Chinese Medicine